Taro 2002 News Archive

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

2/4/2002

Taro Appoints Daniel H. Saks Vice President of Corporate Affairs

Hawthorne, New York, Monday, February 4, 2002 - Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO) today announced that Daniel H. Saks has been appointed to the position of Vice President of Corporate Affairs, with responsibility for Taro’s worldwide corporate and investor communications as well as public relations.

Extensive Global Experience
Mr. Saks brings 23 years of top-level experience to his new position. Most recently, he was Senior Managing Director of FRB/Weber Shandwick Worldwide (formerly FRB/BSMG Worldwide), a global public relations firm, as well as Managing Partner in the Los Angeles office of the Financial Relations Board.

Earlier, Mr. Saks, 53, was Vice President at the Corporate Communications Group in Los Angeles, and before that, a Client Services Manager at Burson-Marsteller.

Mr. Saks has also owned investor relations firms in Los Angeles and Israel, and served as President of Custom News Company, an online information retrieval service providing business news and analysis to corporations and associations. He began his career as an Account Executive at Kekst and Company in New York.

“Dan’s outstanding experience, and his longstanding relationship with Taro, make him the ideal person to join the Company as our recognition grows within our industry and the investment community,” said Barrie Levitt, M.D., Chairman of the Company. “He will be a valuable member of our management team, handling all aspects of corporate communications and investor and media relations.” Taro’s initiatives in these areas have expanded significantly following the company’s successful public offering in October.

Mr. Saks continues in his positions as a Director and Treasurer of the Los Angeles Chapter of the National Investor Relations Institute, and as a member of the Board of Governors of Goodwill Industries of Southern California.

Taro is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

###